REZN Stock Overview
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
The Hash Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.01 |
| 52 Week Low | CA$0.005 |
| Beta | 0.84 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| REZN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -0.6% |
| 1Y | 0% | 50.8% | 3.9% |
Return vs Industry: REZN underperformed the Canadian Pharmaceuticals industry which returned 50.8% over the past year.
Return vs Market: REZN underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| REZN volatility | |
|---|---|
| REZN Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: REZN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine REZN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | n/a | Chris Savoie | www.thehashcorporation.com |
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada. It applies its separation and curing techniques to produce a suite of cannabis resin products, which are natural and free of additives. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019.
The Hash Corporation Fundamentals Summary
| REZN fundamental statistics | |
|---|---|
| Market cap | CA$1.40m |
| Earnings (TTM) | -CA$544.49k |
| Revenue (TTM) | CA$588.30k |
2.4x
P/S Ratio-2.6x
P/E RatioIs REZN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REZN income statement (TTM) | |
|---|---|
| Revenue | CA$588.30k |
| Cost of Revenue | CA$218.76k |
| Gross Profit | CA$369.54k |
| Other Expenses | CA$914.03k |
| Earnings | -CA$544.49k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 62.81% |
| Net Profit Margin | -92.55% |
| Debt/Equity Ratio | -84.5% |
How did REZN perform over the long term?
See historical performance and comparison